8 results match your criteria: "Frankston Private Hospital[Affiliation]"
Phase I/IIa Trial in Advanced Pancreatic Ductal Adenocarcinoma Treated with Cytotoxic Drug-Packaged, EGFR-Targeted Nanocells and Glycolipid-Packaged Nanocells.
Clin Cancer Res
January 2024
EnGeneIC Ltd., Sydney, New South Wales, Australia.
Article Synopsis
- The study evaluated a new EGFR-targeted drug, E-EDV-D682/GC, in patients with advanced pancreatic ductal adenocarcinoma (PDAC) who had no other treatment options.
- Conducted as a phase I/IIa clinical trial, it focused on safety and overall survival, showing that most patients experienced only mild side effects and there were no serious safety concerns.
- The median overall survival was 4.4 months for all patients, but those who completed a treatment cycle had a better outcome of 6.9 months, indicating potential effectiveness of the treatment.
Reply to F. Keane et al.
JCO Precis Oncol
June 2022
Vinod Ganju, MBBS, PASO Medical, Frankston Private Hospital, 5 Susono Way, Frankston, Victoria, Australia; Daniel Croagh, MBBS, PhD, Department of Surgery, Monash University, Clayton, Victoria, Australia; Joanne Lundy, MBBS, PhD, Department of Surgery, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia;Peninsula and Southeast Oncology, Frankston, Victoria, Australia.
A collaborative approach to ROMP TEAP registrar training.
Phys Eng Sci Med
June 2021
GenesisCare, Wembley, WA, Australia.
The Achilles tendon: Management of acute and chronic conditions.
Aust J Gen Pract
November 2020
BMed, BMedSci (Hons), MPH (Dist), GradDipSurgAnat, FRACS (Orth), Senior Adjunct Lecturer, Peninsula Clinical School, Monash University, Vic; Visiting Medical Officer, Peninsula Health, Vic; Orthopaedic Surgeon, Holmesglen Private Hospital, Cabrini Private Hospital, Frankston Private Hospital, Vic.
Background: The prevalence of acute and chronic conditions of the Achilles tendon is increasing among an ageing, active population. These conditions are a common cause of presentation to general practitioners and allied health practitioners. Achilles tendon injuries have a bimodal demographical presentation, with acute injuries commonly occurring in younger people and chronic conditions presenting in patients who are elderly.
View Article and Find Full Text PDFLow-flow apnoeic oxygenation for laryngeal surgery: a prospective observational study.
Anaesthesia
August 2020
Department of Anaesthesia, Monash Health, Clayton, Vic., Australia.
Laryngeal surgery requires a shared airway and close collaboration between surgeon and anaesthetist in order to optimise operating conditions. Apnoeic oxygenation uses the principle of aventilatory mass flow to maintain oxygenation of pulmonary capillary blood under apnoeic conditions while minimising laryngeal movement. Concerns regarding accumulation of carbon dioxide and resultant acidaemia have limited the use of the technique.
View Article and Find Full Text PDFJugular foramen tumour resulting in hypoglossal denervation pseudohypertrophy: a rare and significant cause for tongue asymmetry.
Int J Oral Maxillofac Surg
January 2019
Oral and Maxillofacial Unit, Monash Health, Victoria, Australia.
Paragangliomas of the jugular foramen are rare. They may present with symptoms of compression of the glossopharyngeal or vagus nerves, or due to secretion of catecholamines from chromaffin cells within the tumour. This case describes a rare presentation of glomus tumour.
View Article and Find Full Text PDFSIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer.
J Clin Oncol
May 2016
Guy A. van Hazel, University of Western Australia; Tom Ferguson, Royal Perth Hospital; David Price and Geoff Bower, Mount Medical Center, Perth; Alex Powell, Hollywood Private Hospital, Nedlands, Western Australia; Andrew H. Strickland, Monash Medical Centre, Bentleigh, East Victoria; Vinod Ganju, Frankston Private Hospital Peninsula Oncology Centre, Frankston; Peter Gibbs, Western Hospital, Footscray, Victoria; Euan Walpole, Princess Alexandra Hospital, Woolloongabba; Paul Eliadis, Wesley Medical Centre, Milton, Queensland; Val Gebski, NHMRC Clinical Trials Centre, Camperdown; David N. Cade and Kenneth Thurston, Sirtex Medical Limited, North Sydney, New South Wales, Australia; Volker Heinemann, Ludwig-Maximilian-University of Munich, Munich; Jens Ricke, University Clinic Magdeburg; Hendrik Kroening, Schwerpunktpraxis of Haematology and Oncology, Magdeburg, Germany; Navesh K. Sharma, University of Maryland Medical Center; Fred Moeslein, University of Maryland School of Medicine, Baltimore, MD; Mark Van Buskirk, Data Reduction LLC, Chester, NJ; Michael P.N. Findlay, Cancer Trials New Zealand, Auckland; David Perez, Dunedin Hospital, Dunedin; Bridget A. Robinson, Christchurch Hospital, Christchurch; Richard Isaacs, Palmerston North Hospital, Palmerston, New Zealand; Marc Peeters, Antwerp University Hospital, Antwerp, Belgium; Javier Rodríguez, Clinica Universidad de Navarra, Pamplona, Spain; Ido Wolf and Einat Shacham-Shmueli, Sheba Medical Center, Tel-Hashomer; Thomas Tichler, Shaare-Zedek Medical Center, Jerusalem, Israel; Eveline Boucher, Hopital de Jour, Rennes; and Julien Taieb, Georges Pompidou European Hospital, Paris, France.
Purpose: SIRFLOX was a randomized, multicenter trial designed to assess the efficacy and safety of adding selective internal radiation therapy (SIRT) using yttrium-90 resin microspheres to standard fluorouracil, leucovorin, and oxaliplatin (FOLFOX)-based chemotherapy in patients with previously untreated metastatic colorectal cancer.
Patients And Methods: Chemotherapy-naïve patients with liver metastases plus or minus limited extrahepatic metastases were randomly assigned to receive either modified FOLFOX (mFOLFOX6; control) or mFOLFOX6 plus SIRT (SIRT) plus or minus bevacizumab. The primary end point was progression-free survival (PFS) at any site as assessed by independent centralized radiology review blinded to study arm.
Posterior mediastinal paraspinal angioleiomyoma causing thoracic radiculopathy.
ANZ J Surg
December 2016
Dorevitch Pathology, Melbourne, Victoria, Australia.